[急性脳血管発作の患者における症状性発症とリスク因子]

F A Yusupov¹, A A Yuldashev¹, M Sh Kuldashov¹

¹Osh State University, Osh, Kyrgyz Republic.

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

|September 3, 2025

まとめ

発作は脳卒中のような急性脳疾患によって引き起こされ結果に影響を及ぼしますこのレビューは,脳卒中患者の流行病学,リスク要因,バイオマーカー,および発作の治療をカバーしています.

科学分野:

神経科学
神経科学
内科医学

背景:

発作は異常で過剰な神経活動に起因する
誘発性発作はしばしば急性または慢性の中枢神経系 (CNS) 疾患に関連しています.
脳血管疾患,中枢神経系感染症,炎症,代謝障害は発作を引き起こす一般的な原因です.

研究の目的:

脳血管事故 (CVA) の患者における症状性発作の流行病学,危険因子,バイオマーカー,および治療をレビューする.
心筋梗塞の拡大,死亡率,機能的予後など,発作が脳卒中に与える影響を強調する.

主な方法:

脳血管事故の背景にある症状性発作に焦点を当てた文献レビュー
疫学的データ,特定された危険因子,および関連するバイオマーカーの分析
脳卒中後の発作に対する現在の治療戦略の検討

主要な成果:

脳卒中は特に高齢者の発作やの大きな原因です
脳卒中後の早期発作は酸化ストレスや細胞死によって脳の損傷を悪化させる可能性があります
脳卒中や出血などの特定の脳血管疾患はしばしば発作に関連しています

結論:

脳血管事故後の症状発作は,重大な臨床的課題です.
発作を誘発する要因や危険因子やバイオマーカーの理解は効果的な管理に不可欠です
発作の適時かつ適切な治療は,二次性脳損傷を軽減し,患者の治療結果を改善するために不可欠です.

キーワード:

脳血管疾患流行病学についてエピレプシーリスク要因発作についてストローク

さらに関連する動画

07:07

Inducing Post-Traumatic Epilepsy in a Mouse Model of Repetitive Diffuse Traumatic Brain Injury

Published on: February 10, 2020

10.7K

07:58

Preparing Undercut Model of Posttraumatic Epileptogenesis in Rodents

Published on: September 15, 2011

9.4K

関連する概念動画

01:24

Epilepsy and Seizures: Overview

275

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...

275

01:13

Seizures: Classification

584

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:

584

01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

445

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

445

01:20

Antiepileptic Drugs: Potassium Channel Activators

274

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...

274

01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

635

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

635

01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...

関連する実験動画